Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


1 Am J Gastroenterol
1 BMC Gastroenterol
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 Gut
2 J Hepatol
1 J Infect Dis
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Gastroenterol

  1. CUADRADO A, Llerena S, Cobo C, Pallas JR, et al
    Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0157.
    PubMed     Text format     Abstract available

    BMC Gastroenterol

  2. NGUYEN HH, Khathlan A, Fritzler MJ, Swain MG, et al
    A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity.
    BMC Gastroenterol. 2018;18:97.
    PubMed     Text format     Abstract available

    Eur J Gastroenterol Hepatol

  3. VIEJO LG, Herola AG, Lloret IS, Ruano FS, et al
    Screening of hepatitis C virus infection in adult general population in Spain.
    Eur J Gastroenterol Hepatol. 2018 Jun 22. doi: 10.1097/MEG.0000000000001190.
    PubMed     Text format     Abstract available


  4. ESTEBAN R, Pineda JA, Calleja JL, Casado M, et al
    Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With HCV genotype 3 Infection and Cirrhosis.
    Gastroenterology. 2018 Jun 26. pii: S0016-5085(18)34684.
    PubMed     Text format     Abstract available


  5. LEMOINE M, Tillmann HL
    What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? 'Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus'.
    Gut. 2018 Jun 29. pii: gutjnl-2018-316438. doi: 10.1136/gutjnl-2018-316438.
    PubMed     Text format    

    J Hepatol

  6. ROCA SUAREZ AA, Baumert TF, Lupberger J
    Beyond viral dependence: The pathological consequences of HCV-induced EGF signaling.
    J Hepatol. 2018 Jun 21. pii: S0168-8278(18)32118.
    PubMed     Text format    

  7. MARSHALL AD, Pawlotsky JM, Lazarus JV, Aghemo A, et al
    The removal of DAA restrictions in Europe - one step closer to eliminating HCV as a major public health threat.
    J Hepatol. 2018 Jun 27. pii: S0168-8278(18)32169.
    PubMed     Text format     Abstract available

    J Infect Dis

  8. HELFRITZ FA, Bojkova D, Wanders V, Kuklinski N, et al
    Methylene Blue Treatment of Grafts during Cold Ischemia time Reduces the Risk of HCV Transmission.
    J Infect Dis. 2018 Jun 23. pii: 5043304. doi: 10.1093.
    PubMed     Text format     Abstract available

    PLoS One

  9. YEN YH, Kuo FY, Kee KM, Chang KC, et al
    APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level.
    PLoS One. 2018;13:e0199760.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  10. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Text format     Abstract available


  11. SAGESHIMA J, Troppmann C, McVicar JP, Santhanakrishnan C, et al
    Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients.
    Transplantation. 2018;102:1179-1187.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.